2013
DOI: 10.1021/cb4006744
|View full text |Cite
|
Sign up to set email alerts
|

Moenomycin Resistance Mutations in Staphylococcus aureus Reduce Peptidoglycan Chain Length and Cause Aberrant Cell Division

Abstract: Staphylococcus aureus is a Gram-positive pathogen with an unusual mode of cell division in that it divides in orthogonal rather than parallel planes. Through selection using moenomycin, an antibiotic proposed to target peptidoglycan glycosyltransferases (PGTs), we have generated resistant mutants containing a single point mutation in the active site of the PGT domain of an essential peptidoglycan (PG) biosynthetic enzyme, PBP2. Using cell free polymerization assays, we show that this mutation alters PGT activi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
61
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1
1

Relationship

3
6

Authors

Journals

citations
Cited by 52 publications
(62 citation statements)
references
References 53 publications
1
61
0
Order By: Relevance
“…To obtain short peptidoglycan oligomers, we incubated synthetic Lipid II with a mutant form of S. aureus SgtB, a monofunctional peptidoglycan glycosyltransferase that polymerizes Lipid II. The mutant, SgtB*, contains a Y181D amino acid substitution in the active site cleft where the elongating polymer binds 33 , and as a result products are released prematurely (Fig. 2b).…”
Section: Resultsmentioning
confidence: 99%
“…To obtain short peptidoglycan oligomers, we incubated synthetic Lipid II with a mutant form of S. aureus SgtB, a monofunctional peptidoglycan glycosyltransferase that polymerizes Lipid II. The mutant, SgtB*, contains a Y181D amino acid substitution in the active site cleft where the elongating polymer binds 33 , and as a result products are released prematurely (Fig. 2b).…”
Section: Resultsmentioning
confidence: 99%
“…As part of the cell wall stimulon 22 , mgt is positively regulated by cell wall stress and participates in the polymerization of lipid II into nascent peptidoglycan 23 . Recent work has shown that mgt mutations cause peptidoglycan chain length reduction as well as alterations in cellular morphology and division site placement 24 .…”
Section: Resultsmentioning
confidence: 99%
“…To compare the stem peptide preferences of Ef PBPX, Sg PBPX, and Sa PBP4, we made uncrosslinked peptidoglycan oligomers from the six Lipid II variants by incubating them with SgtB Y181D (SgtB*), a peptidoglycan polymerase that makes short peptidoglycan chains. 12 BDL and PBPs were then added and the reaction products analyzed by western blot. Sa PBP4 labeled all the substrates, although four-fold higher concentrations of 4 – 6 were required to produce enough labeled material to detect (Figure S7).…”
mentioning
confidence: 99%